Stay updated on VB-111 Combo in Recurrent Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the VB-111 Combo in Recurrent Glioblastoma Clinical Trial page.

Latest updates to the VB-111 Combo in Recurrent Glioblastoma Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0. The study record remains inaccessible and displays a 403 Forbidden message.SummaryDifference0.2%

- Check13 days agoChange DetectedA banner appears above the page announcing that NIH content is transitioning from the term “Artificial Intelligence” to “Super Intelligence.” The study record content remains unavailable.SummaryDifference1%

- Check20 days agoChange DetectedThe site footer revision label updates from v3.7.1 to v3.7.2, while the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedThe footer’s site revision number changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check41 days agoChange DetectedA 403 Forbidden page appears with the site header/footer and a Home link, indicating access to the study page is blocked.SummaryDifference0.5%

- Check48 days agoChange DetectedRevision: v3.7.0 was added to the page, and a large set of metadata terms and sponsor-related labels were removed from the study record.SummaryDifference17%

Stay in the know with updates to VB-111 Combo in Recurrent Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VB-111 Combo in Recurrent Glioblastoma Clinical Trial page.